Microbes in Alzheimer's Disease Pilot Awards Request for Applications 2023

Funding Agency:
Duke University

The purpose of these $85,000 pilot awards is to stimulate and support collaborative, innovative research on the potential role of microbes or pathogens in the development of Alzheimer’s disease (AD). 

Successful applications will propose feasible projects or experiments to test specific hypotheses, generate strong preliminary data, or develop a critical resource to advance this field of inquiry. All types of research, from any point along the translational spectrum, are welcome. Topics of interest include, but are not limited to:

  • Associations between specific pathogens or microbiomes and AD risk or pathology
  • Advancement of new models to investigate the role of microbes or pathogens in AD
  • Understanding the consequences of infections, antimicrobials, or vaccines on AD or markers of AD risk

Letters of intent are due by July 10, 2023.

Agency Website

Eligibility Requirements

  1. Principal investigator (PI) must be faculty at Duke University.  Collaborators from other institutions are allowed, but transfer of funding may result in delays or incur indirect costs from other institutions, which must be deducted from the $85,000 pilot budget.  If subawards are proposed, the application must address how these challenges will be handled and provide letters from partner institutions in support of the proposed plan (e.g., agreements regarding indirect cost structure).
  2. Priority consideration will be given to applications that incorporate any of the following in the study team:
  • Inter-disciplinary collaborations
  • Substantial involvement of a mentored student or trainee, or an early stage investigator (ESI)
  • Individuals from traditionally under-represented groups in research (as defined by NIH)



Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

July 10, 2023